Back to Trades
Dhingra Kapil
DirectorCIK 0001456849
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 3
- Active
- 2025–2026
Across 4 filings between 2025–2026, Dhingra Kapil, Director, has disclosed $1.1M in transactions — spread across 3 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $408.5K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Nov 3 | REPL Replimune Group, Inc. | Dhingra Kapil | Director | Sell | $408.5K |
| Jun 29 | BDTX Black Diamond Therapeutics, Inc. | Dhingra Kapil | Insider | Award | $68.4K |
| Apr 7 | REPL Replimune Group, Inc. | Dhingra Kapil | Director | Award | $338.6K |
| Aug 19 | CRGX CARGO Therapeutics, Inc. | Dhingra Kapil | Insider | Disposed | $108.8K |
4 filings